(Q50554742)

English

Characterization and comparison of 'standard' and 'young' tumour-infiltrating lymphocytes for adoptive cell therapy at a Danish translational research institution.

scientific article published in February 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955245%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Characterization and comparison of 'standard' and 'young' tumour-infiltrating lymphocytes for adoptive cell therapy at a Danish translational research institution (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955245%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955245%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Inge Marie Svane

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955245%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955245%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Mads Hald Andersen

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955245%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

E Ellebaek

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955245%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

P T Straten

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955245%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

1 February 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955245%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Scandinavian Journal of Immunology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955245%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

75

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955245%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955245%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

157-167

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955245%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Adoptive cell therapy for the treatment of patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

Increased intensity lymphodepletion enhances tumor treatment efficacy of adoptively transferred tumor-specific T cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

White paper on adoptive cell therapy for cancer with tumor-infiltrating lymphocytes: a report of the CTEP subcommittee on adoptive cell therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

Establishment and large-scale expansion of minimally cultured "young" tumor infiltrating lymphocytes for adoptive transfer therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

Minimally cultured tumor-infiltrating lymphocytes display optimal characteristics for adoptive cell therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

Persistence of tumor infiltrating lymphocytes in adoptive immunotherapy correlates with telomere length.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

Modulation by IL-2 of CD70 and CD27 expression on CD8+ T cells: importance for the therapeutic effectiveness of cell transfer immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

CD8+ Enriched “Young” Tumor Infiltrating Lymphocytes Can Mediate Regression of Metastatic Melanoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

Focus on adoptive T cell transfer trials in melanoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

Minimally cultured or selected autologous tumor-infiltrating lymphocytes after a lympho-depleting chemotherapy regimen in metastatic melanoma patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

Impact of clinical and pathologic features on tumor-infiltrating lymphocyte expansion from surgically excised melanoma metastases for adoptive T-cell therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

Expansion and characterization of human melanoma tumor-infiltrating lymphocytes (TILs)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

Identification of novel and widely expressed cancer/testis gene isoforms that elicit spontaneous cytotoxic T-lymphocyte reactivity to melanoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

Quantum dots thermal stability improves simultaneous phenotype-specific telomere length measurement by FISH-flow cytometry

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

Assessment of telomere length, phenotype, and DNA content.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

Simultaneous flow cytometric analysis of two cell surface markers, telomere length, and DNA content

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

Immunogenicity of Bcl-2 in patients with cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

MHC-based detection of antigen-specific CD8+ T cell responses.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

Ex vivo identification, isolation and analysis of tumor-cytolytic T cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

Transition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

Adoptive immunotherapy for cancer: building on success

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

Cutting edge: cytolytic effector function in human circulating CD8+ T cells closely correlates with CD56 surface expression.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

Induction of CD56 and TCR-independent activation of T cells with aging.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

New aspects of NK cell subset identification and inference of NK cells' regulatory capacity by assessing functional and genomic profiles

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

CD56bright natural killer (NK) cells: an important NK cell subset.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

NK cell dysfunction with down-regulated CD16 and up-regulated CD56 molecules in patients with esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

Expansion of CD16-negative natural killer cells in the peripheral blood of patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

Identification and characterization of a tumor infiltrating CD56(+)/CD16 (-) NK cell subset with specificity for pancreatic and prostate cancer cell lines.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

Characterization of ex vivo expanded tumor infiltrating lymphocytes from patients with malignant melanoma for clinical application

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

MART-1-specific melanoma tumor-infiltrating lymphocytes maintaining CD28 expression have improved survival and expansion capability following antigenic restimulation in vitro

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

Activation-Induced Expression of CD56 by T Cells Is Associated With a Reprogramming of Cytolytic Activity and Cytokine Secretion Profile In Vitro

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02640.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50554742&oldid=2109609417"